Mar 6, 2026 08:00AM
Feb 26, 2026 08:01AM
Feb 26, 2026 08:00AM
Nov 12, 2025 08:00AM
Oct 24, 2025 11:40AM
Oct 24, 2025 11:39AM
Oct 13, 2025 04:01PM PMV Pharmaceuticals to present rezatapopt data at cancer conference
Oct 13, 2025 04:01PM
Sep 10, 2025 01:45PM
Sep 10, 2025 07:00AM
Sep 10, 2025 07:00AM
Aug 7, 2025 08:42AM
May 9, 2025 08:00AM
Mar 3, 2025 08:00AM PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights
Nov 7, 2024 08:00AM
Oct 23, 2024 08:00AM
Aug 8, 2024 08:00AM
May 29, 2024 07:04AM
May 29, 2024 07:00AM
May 9, 2024 08:00AM
Mar 27, 2024 08:00AM PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
Mar 18, 2024 04:01PM
Mar 18, 2024 04:01PM
Feb 29, 2024 04:01PM
Jan 18, 2024 04:01PM
Jan 18, 2024 04:01PM
Jan 5, 2024 04:01PM
Jan 5, 2024 04:01PM PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
Dec 27, 2023 04:16PM
Nov 9, 2023 08:00AM
Oct 12, 2023 12:32PM
Oct 12, 2023 12:30PM
Oct 11, 2023 12:00PM
Sep 20, 2023 04:05PM
Aug 9, 2023 08:00AM PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
May 10, 2023 08:00AM
Mar 1, 2023 08:00AM
Nov 8, 2022 08:00AM
Nov 4, 2022 08:02AM
Nov 4, 2022 08:00AM
Aug 9, 2022 08:00AM
Jul 18, 2022 08:07AM PMV Pharmaceuticals (PMVP) Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA in Patients with Advanced Solid Tumors
Jul 18, 2022 08:00AM
Jun 7, 2022 12:00PM
Jun 7, 2022 12:00PM
Nov 12, 2021 07:15AM
Aug 13, 2021 08:00AM
May 14, 2021 08:00AM
Mar 3, 2021 04:01PM PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
Nov 23, 2020 08:11AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All